Search

Your search keyword '"Abraham, Ivo"' showing total 276 results

Search Constraints

Start Over You searched for: Author "Abraham, Ivo" Remove constraint Author: "Abraham, Ivo" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
276 results on '"Abraham, Ivo"'

Search Results

1. Disability-adjusted life years from bone and joint infections associated with antimicrobial resistance: an insight from the 2019 Global Burden of Disease Study

3. A Least Absolute Shrinkage and Selection Operator-Derived Predictive Model for Postoperative Respiratory Failure in a Heterogeneous Adult Elective Surgery Patient Population

4. A LASSO-DERIVED PREDICTIVE MODEL FOR POSTOPERATIVE RESPIRATORY FAILURE IN A HETEROGENEOUS ADULT ELECTIVE SURGERY PATIENT POPULATION

5. Outcomes and risk factors for delayed-onset postoperative respiratory failure: a multi-center case-control study by the University of California Critical Care Research Collaborative (UC3RC)

15. Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis

22. Examining Risk of Heart Failures With Trastuzumab (Herceptin) Use Among Patients With HER2+ Breast Cancer Using Surveillance, Epidemiology, and End Results (Seer) Medicare: A Retrospective Cohort Study

25. Polytomous Rasch Analyses of Surgeons' Decision-Making on Choice of Procedure in Endoscopic Lumbar Spinal Stenosis Decompression Surgeries.

26. What to expect in 2024: important health economics and outcomes research (HEOR) trends.

27. Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma

31. The Changing Environment in Postgraduate Education in Orthopedic Surgery and Neurosurgery and Its Impact on Technology-Driven Targeted Interventional and Surgical Pain Management: Perspectives from Europe, Latin America, Asia, and The United States

32. Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey

35. Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: Simulation study

38. Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals

39. What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends

40. Optimizing Postpartum Care in Arizona

47. sj-docx-1-aop-10.1177_10600280221146878 – Supplemental material for Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

48. Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

Catalog

Books, media, physical & digital resources